Market Outlook

By 2035, the U.S. Home-Based Care Devices Market is expected to reach approximately USD 70.58 billion, expanding at a CAGR of 8.35% during the forecast period 2026–2035. The market was valued at approximately USD 31.65 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The U.S. home-based care devices industry is moving from a traditionally fragmented durable medical equipment market toward an integrated clinical technology ecosystem capable of supporting diagnosis, treatment, rehabilitation, chronic disease management, post-acute recovery, and increasingly acute-level care inside the patient’s residence. The market includes medical-grade monitoring devices, respiratory and sleep therapy equipment, diabetes management technologies, medication delivery devices, mobility and patient-support equipment, home dialysis systems, infusion technologies, wound-care devices, and connected platforms that allow clinicians to supervise patients remotely.

Demographic pressure is fundamental to long-term market demand. The U.S. population aged 65 years and older exceeded 61 million in 2024 and represented approximately 18% of the population. The aging of the Baby Boomer population is increasing the number of patients living with multiple chronic conditions, impaired mobility, respiratory disease, diabetes, cardiovascular disease, renal disease, and functional limitations that can be managed partly or entirely at home. Home-based equipment increasingly enables these patients to remain outside institutional care while maintaining clinical visibility.

The economic environment also supports this transition. U.S. spending through freestanding home health agencies reached approximately USD 169.4 billion in 2024, increasing more than 10% year over year. Separately, national retail spending on durable medical equipment reached approximately USD 86.4 billion. Only a portion of these expenditure categories falls within the specific device scope of this report, but they demonstrate the substantial healthcare infrastructure and payer expenditure already supporting care outside conventional hospitals.

Historical demand increased from an estimated USD 23.65 billion in 2021 to USD 29.34 billion in 2024. Growth during this period was supported by increased adoption of continuous glucose monitoring, positive airway pressure systems, home oxygen technologies, remote patient monitoring equipment, connected blood-pressure and cardiac monitoring, mobility equipment, and post-discharge care programs. The COVID-era acceleration of home monitoring also created lasting changes in patient and provider acceptance of medical technology outside clinical facilities.

The market reached approximately USD 31.65 billion in 2025, as home-based care became increasingly integrated into health-system capacity planning rather than treated simply as an ancillary care channel. Between 2026 and 2035, revenue expansion will increasingly come from connected devices, recurring sensor and consumable models, home-based specialty treatment, higher-acuity monitoring, intelligent respiratory platforms, automated medication delivery, and hospital-to-home clinical programs.

The market-sizing framework used in this report includes medical devices and equipment intended or routinely deployed for care inside the patient’s residence. It excludes skilled nursing labor, home health aides, hospice service revenue, pharmaceuticals, non-medical consumer wellness products, and professional telehealth service revenue. This distinction is important because the broader U.S. home healthcare industry is substantially larger than the home-based medical device market analyzed here.

 

Introduction

According to the U.S. Home-Based Care Devices Market Report, care delivery in the United States is undergoing a structural decentralization. Hospitals will remain essential for surgery, trauma, critical care, intensive diagnostics, and complex intervention, but a growing portion of disease management can now be performed through medical technologies located inside the home.

The FDA defines home-use medical devices broadly as devices intended for use outside professional healthcare facilities. This means the commercial addressable market is no longer confined to traditional oxygen equipment, hospital beds, walkers, wheelchairs, and glucose meters. It increasingly includes digitally connected monitoring systems, continuous sensors, automated therapy systems, compact respiratory platforms, portable infusion technologies, intelligent medication-delivery devices, wearable diagnostic systems, and technologies used within hospital-at-home programs.

The clinical need is substantial. Chronic disease affects a majority of U.S. adults, while hypertension affects more than four in ten adults. Diabetes affects approximately 38 million Americans, with tens of millions more living with prediabetes. COPD affects millions of adults and becomes substantially more prevalent among older age groups. These conditions require repeated measurement, medication management, behavioral adjustment, therapy adherence, and early identification of deterioration, all of which create opportunities for home-based medical devices.

Diabetes demonstrates how the home-device ecosystem is evolving. Historically, home diabetes management centered on blood glucose meters and test strips. Current care increasingly includes continuous glucose monitors, insulin pumps, automated insulin-delivery systems, connected smart pens, smartphone applications, data-sharing platforms, and clinician dashboards. This transition converts a periodic measurement market into a continuous data and therapy ecosystem.

Respiratory care is undergoing a similar transformation. Oxygen concentrators, nebulizers, CPAP devices, BiPAP systems, ventilators, pulse oximeters, airway-clearance systems, and connected adherence platforms allow chronic respiratory and sleep disorders to be managed outside institutional settings. In COPD, diagnosed disease prevalence rises markedly with age, making respiratory equipment particularly exposed to U.S. demographic aging.

Home-based care is also becoming relevant to hospital economics. Medicare’s Acute Hospital Care at Home framework has demonstrated that selected inpatient-level services can be delivered in patients’ residences when appropriate clinical monitoring, staffing, escalation pathways, and device infrastructure are available. Congressional extension of this care pathway through 2030 materially improves strategic visibility for health systems evaluating hospital-at-home capacity.

For device manufacturers, the opportunity therefore extends beyond selling equipment to individual patients. Future market leadership will increasingly depend on supporting complete care pathways spanning device placement, onboarding, connectivity, monitoring, clinician workflow integration, consumable replenishment, technical support, reimbursement documentation, patient adherence, and longitudinal clinical data.

 

Key Market Drivers: What’s Fueling the U.S. Home-Based Care Devices Market Boom?

The first major driver is the rapid aging of the American population. More than 61 million Americans were already aged 65 years or older in 2024, and this population is continuing to expand. Older patients generate disproportionate demand for oxygen therapy, sleep apnea treatment, glucose monitoring, mobility equipment, fall-prevention technologies, hospital beds, pressure-relief surfaces, home dialysis, blood-pressure monitoring, rehabilitation equipment, and medication-management systems.

Aging creates particularly strong demand because older adults frequently have multiple overlapping conditions rather than isolated disease. A patient with heart failure may also have diabetes, impaired mobility, hypertension, chronic kidney disease, and sleep-disordered breathing. Home-based care therefore requires combinations of devices rather than a single equipment category. This creates opportunities for integrated suppliers and connected platforms capable of consolidating multiple data streams.

The second major driver is chronic disease prevalence. Approximately 38 million Americans are living with diabetes, while more than 40% of U.S. adults have hypertension. COPD remains highly prevalent among older adults, particularly in nonmetropolitan communities. These conditions are characterized by repeated monitoring requirements and substantial risk of avoidable hospitalization when deterioration is detected late.

The third driver is healthcare cost pressure. U.S. national healthcare expenditure exceeded USD 5 trillion in 2024. Health systems, Medicare Advantage organizations, commercial insurers, accountable care organizations, and risk-bearing medical groups are therefore increasingly interested in technologies that can reduce unnecessary emergency utilization, shorten hospital stays, improve discharge readiness, and identify deterioration before it requires expensive acute care.

A fourth driver is the normalization of remote physiologic monitoring. Medicare reimbursement established a durable economic pathway for clinicians to remotely manage automatically transmitted physiologic information from qualified medical devices. Blood pressure, weight, pulse oximetry, glucose, respiratory metrics, cardiac rhythm, and other parameters can therefore become part of reimbursable longitudinal disease management when applicable requirements are satisfied.

A fifth driver is the expansion of hospital-at-home and higher-acuity home care. The Acute Hospital Care at Home program has moved home-based treatment beyond traditional post-acute services. The model requires medical-grade monitoring, oxygen, infusion equipment, connectivity, mobile diagnostics, safety systems, and rapid escalation capacity. As hospitals gain confidence with this operating model, home-compatible devices designed for professional-level reliability but consumer-level usability should benefit.

The sixth driver is patient preference for aging in place. Many older Americans prefer to remain in their own residences rather than transition to institutional care. Mobility devices, patient lifts, adjustable beds, bathroom safety equipment, pressure-management systems, home monitoring, respiratory devices, and connected emergency-response systems help extend the period during which independent or caregiver-supported living remains viable.

The seventh driver is caregiver economics. Family members provide substantial informal care throughout the United States. Devices that simplify measurement, automate therapy, reduce manual handling, improve fall safety, provide medication reminders, or remotely alert caregivers can reduce the practical burden of home-based disease management.

The eighth driver is increasing consumer familiarity with connected medical technology. Smartphones, Bluetooth-enabled devices, cloud dashboards, wearable sensors, and digital interfaces have reduced the behavioral barrier to home medical technology. However, clinically successful systems must remain considerably more reliable than general consumer wellness electronics. The commercial advantage therefore lies with manufacturers capable of combining intuitive design with medical-grade accuracy, cybersecurity, durability, and clinical workflow compatibility.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. home-based care devices market is shifting from isolated hardware toward intelligent care environments. Historically, many home medical devices operated independently. A patient could have a blood-pressure monitor from one manufacturer, a glucose device from another, a CPAP platform from a third, and a pulse oximeter from a fourth, with limited interoperability among systems.

The next competitive cycle is centered on integration. Manufacturers are developing devices that automatically transmit information, identify clinically important trends, support remote intervention, and integrate into electronic health records or care-management platforms. This reduces the dependence on patients manually documenting measurements and creates more actionable information for clinicians.

Continuous glucose monitoring is one of the strongest examples of this transition. CGM adoption has expanded beyond traditional intensive insulin management into broader metabolic monitoring. FDA clearance of over-the-counter CGM systems has lowered access barriers and created a direct pathway for eligible consumers to obtain continuous glucose information without conventional prescription workflows. In 2026, the U.S. regulatory environment expanded further with clearance of an OTC CGM option for younger users who meet the indicated criteria.

Respiratory care innovation is also increasingly software-enabled. Modern PAP devices can remotely transmit adherence information, identify mask-leak problems, support pressure optimization, and enable home medical equipment providers to intervene before patients abandon therapy. Portable oxygen concentrators continue to improve mobility relative to traditional stationary oxygen systems, while connected ventilatory support technologies can improve oversight of higher-risk patients.

Home dialysis represents another strategically important innovation area. Traditional dialysis requires repeated travel to treatment centers several times each week, creating substantial patient and caregiver burden. Compact home hemodialysis and peritoneal dialysis technologies can move treatment closer to the patient while giving appropriately selected individuals greater flexibility. The opportunity extends beyond the dialysis machine itself into water-management technologies, disposables, connected monitoring, supply logistics, and patient training.

Mobility technology is evolving through lighter wheelchairs, advanced seating, powered mobility, pressure-management solutions, transfer systems, smart controls, and connected safety technologies. The economic value proposition is increasingly tied to preventing falls, pressure injuries, caregiver musculoskeletal injury, and avoidable institutionalization rather than simply providing transportation.

Home infusion technology is becoming smaller, more programmable, and more portable. Ambulatory infusion pumps enable antibiotics, nutrition, oncology-related supportive therapy, pain management, and other treatments to be delivered outside hospitals when clinically appropriate. Manufacturers must compete on dose accuracy, cybersecurity, battery reliability, ease of programming, alarm management, and compatibility with home-infusion provider workflows.

Remote cardiac and vital-sign monitoring is another major innovation area. Patch-based ECG systems, connected blood-pressure monitors, pulse oximeters, digital scales, and multi-parameter monitoring devices allow episodic disease management to become continuous surveillance. Algorithms can prioritize patients showing deterioration rather than requiring clinicians to review every normal data point.

Artificial intelligence will increasingly influence device differentiation, but its highest-value role will be workflow prioritization rather than stand-alone automation. Home-monitoring programs can generate very large quantities of information. Algorithms capable of identifying meaningful deviations, reducing false alarms, forecasting deterioration, and directing clinician attention toward the highest-risk patients can materially improve program economics.

Human factors engineering will be equally important. Home users may be elderly, visually impaired, cognitively limited, physically disabled, technologically inexperienced, or supported by an equally elderly caregiver. Devices designed primarily around hospital-trained operators can fail when transferred into homes. Manufacturers that simplify setup, reduce maintenance requirements, create intuitive alerts, automate connectivity, and design for variable living environments will have an important competitive advantage.

 

Segmentation Insights

The U.S. Home-Based Care Devices Market is segmented on the basis of device category, clinical application, care delivery model, technology and connectivity, and region.

 

By Device Category

Remote Diagnostic and Monitoring Devices

Remote diagnostic and monitoring devices represent one of the largest and fastest-expanding segments of the U.S. market. The category includes blood-pressure monitors, continuous glucose monitors, conventional glucose meters, pulse oximeters, digital scales, home ECG technologies, ambulatory cardiac monitors, thermometers, connected spirometry, multi-parameter monitoring systems, and other physiologic sensors.

The segment represented an estimated USD 8.78 billion in 2025, or approximately 28% of the device market modeled in this report. Growth is supported by recurring sensor consumption, increasing remote monitoring reimbursement, hospital-at-home programs, chronic disease management, and the movement from intermittent measurements toward continuous data capture.

The competitive objective is increasingly to convert raw measurements into clinically useful information. Devices capable of automatic transmission, trend detection, clinician integration, and reliable patient identification are better positioned than isolated measurement tools.

Respiratory and Sleep Therapy Devices

Respiratory and sleep therapy devices generated approximately USD 7.20 billion in 2025. This category includes CPAP and BiPAP equipment, oxygen concentrators, oxygen-delivery systems, nebulizers, ventilators, airway-clearance technologies, respiratory assist devices, suction equipment, and supporting accessories.

Demand is structurally supported by COPD, obstructive sleep apnea, chronic respiratory failure, neuromuscular disease, and post-acute respiratory care. COPD prevalence becomes considerably higher among older Americans, and rural populations can face both higher respiratory disease burden and lower specialist access.

Recurring masks, tubing, filters, cannulas, replacement accessories, and service relationships give respiratory therapy attractive recurring-revenue characteristics. Manufacturers increasingly differentiate through noise reduction, portability, battery performance, adherence analytics, comfort, and remote therapy management.

Diabetes and Medication-Delivery Devices

Diabetes and medication-delivery devices represented approximately USD 5.91 billion in 2025. Products include CGM systems, glucose meters, insulin pumps, automated insulin-delivery systems, smart insulin pens, injection-support technologies, and connected medication-management devices.

Diabetes is particularly attractive commercially because treatment occurs primarily outside hospitals and requires continuous patient participation. Approximately 38 million Americans have diabetes, creating one of the largest identifiable chronic-disease device populations in the country.

CGM and automated insulin delivery are shifting diabetes technology toward a recurring, software-enabled platform model. Manufacturers compete not only on sensor accuracy or pump hardware but also on wear duration, interoperability, automated dosing algorithms, smartphone integration, payer coverage, and user experience.

Mobility, Rehabilitation and Patient-Support Devices

Mobility and patient-support devices represented approximately USD 6.08 billion in 2025. The category includes wheelchairs, powered mobility systems, walkers, canes, patient lifts, home hospital beds, support surfaces, transfer equipment, rehabilitation equipment, bathroom safety systems, and pressure-management technologies.

This segment is deeply exposed to demographic aging and disability trends. Demand is particularly strong among patients recovering from surgery or stroke, individuals with neurological disease, frail older adults, and people with chronic musculoskeletal limitations.

Purchasing decisions are highly influenced by reimbursement, durability, service networks, local HME supplier relationships, customization requirements, and caregiver usability. Advanced seating and powered mobility remain premium subsegments, while basic walking aids and beds provide a stable recurring equipment base.

Home Renal, Infusion, Wound and Specialty Care Devices

Home renal, infusion, wound, and specialty technologies represented approximately USD 3.68 billion in 2025. The category includes home dialysis systems, ambulatory infusion pumps, enteral-feeding equipment, negative-pressure wound therapy systems, compression devices, suction equipment, specialty monitoring, and associated home treatment technologies.

Although smaller than monitoring or respiratory equipment, this is one of the most strategically important segments because it enables high-cost clinical services to migrate away from hospitals and treatment centers.

Home dialysis can reduce travel burden and increase treatment flexibility for appropriately selected patients. Home infusion can shift selected medication administration outside hospital outpatient departments. Negative-pressure wound therapy allows complex wound-management protocols to continue after discharge. These technologies therefore directly participate in site-of-care substitution.

 

By Clinical Application

Cardiometabolic and Diabetes Management

Cardiometabolic disease represents the largest application pool because hypertension, diabetes, obesity-associated disease, heart failure, and vascular risk affect very large patient populations. Connected blood-pressure monitors, scales, CGMs, cardiac monitors, medication-delivery technologies, and pulse oximeters are increasingly used together in longitudinal programs.

The highest value does not come from measuring one parameter independently. It comes from combining trends to identify deterioration before hospitalization. For example, weight increase, blood-pressure change, oxygen desaturation, reduced activity, and abnormal heart rhythm may together signal worsening heart failure more effectively than any single measurement.

Respiratory and Sleep Disorders

Respiratory and sleep disorders are major applications for home-based technology because therapy naturally occurs for long periods outside facilities. CPAP, BiPAP, home oxygen, ventilation, nebulization, pulse oximetry, and airway-clearance devices provide a large recurring installed base.

Demand is strongest among older populations and states with elevated respiratory disease burden. Home respiratory equipment is also strategically important for rural areas because transportation distance can make repeated facility-based treatment difficult.

Renal and Specialty Infusion Care

Renal disease and infusion therapy represent a smaller patient population but high device intensity. Home dialysis requires capital equipment, disposable supplies, monitoring, patient training, and logistics. Home infusion similarly requires pump technology, administration supplies, pharmacy coordination, and clinical oversight.

As payers and providers pursue lower-cost sites of care, specialty technologies capable of safely replacing facility-based treatment can achieve above-average growth.

Mobility, Neurological and Rehabilitation Care

Neurological disorders, stroke recovery, arthritis, frailty, musculoskeletal disease, spinal injury, and age-related mobility impairment support demand for wheelchairs, walkers, lifts, adjustable beds, pressure-relieving surfaces, and rehabilitation technologies.

The value proposition extends beyond mobility. Appropriate home equipment can reduce falls, prevent pressure injuries, lower caregiver physical strain, facilitate discharge from institutional care, and support independence.

Post-Acute, Complex and Multi-Chronic Care

Post-acute and multi-chronic care is becoming one of the most commercially important applications because hospital systems increasingly need to maintain clinical visibility after discharge. Patients may require combinations of monitoring, oxygen, infusion, mobility equipment, wound therapy, rehabilitation, and medication-management technology.

This application is especially important for reducing 30-day readmission risk. Manufacturers positioned within discharge workflows can gain access to patients at the moment equipment decisions are being made, creating strategic relationships with health systems and home-care organizations.

 

By Care Delivery Model

Patient and Family Caregiver-Managed Home Care

Patient and caregiver-managed care represents the largest installed base. Devices in this segment must combine reliability with intuitive operation because the primary operator may have no clinical training.

Ease of setup, simple instructions, automatic connectivity, low maintenance, clear alarms, accessible customer support, and predictable supply replacement are critical purchasing factors.

Home Health Agency-Supported Care

Home health agencies use monitoring, wound-care, respiratory, mobility, and rehabilitation technologies to support patients receiving skilled services at home. U.S. spending through freestanding home health agencies reached approximately USD 169.4 billion in 2024, demonstrating the economic scale of the surrounding care-delivery channel.

Device companies serving agencies must address clinician efficiency, inventory control, infection prevention, documentation, training, and interoperability.

Hospital-at-Home and Health-System Programs

Hospital-at-home is the highest-acuity care model within the market. Participating programs may require continuous or frequent monitoring, oxygen, infusion, mobile diagnostics, remote clinical communication, medication-delivery systems, and escalation protocols.

Congressional extension of Medicare’s Acute Hospital Care at Home framework through September 2030 provides substantially greater planning visibility than short-term waiver extensions. Health systems can therefore evaluate home-care technology as a strategic service-line investment rather than an emergency temporary measure.

HME and DME Supplier-Supported Care

Home medical equipment suppliers remain essential because many device categories require delivery, fitting, installation, training, maintenance, documentation, reimbursement processing, and recurring consumable supply.

Manufacturers with strong distribution relationships can achieve better patient onboarding and service reliability, particularly in respiratory therapy, mobility, hospital beds, and oxygen equipment.

Specialty Home Therapy Providers

Specialty home infusion, dialysis, respiratory, wound-care, and complex-care organizations represent a high-value customer segment. These providers generally prioritize equipment reliability, utilization visibility, logistics integration, and low service interruption because device failures can directly disrupt treatment.

 

By Technology and Connectivity

Conventional Non-Connected Devices

Conventional devices continue to represent an important part of the market, particularly in basic mobility, beds, manual support equipment, and low-complexity monitoring. They are favored where clinical connectivity provides limited incremental value or where broadband and digital literacy are barriers.

Bluetooth and Wi-Fi Connected Devices

Bluetooth and Wi-Fi connectivity is increasingly standard across blood-pressure monitors, glucose devices, scales, PAP systems, pulse oximeters, and medication-management technologies. These systems typically connect through smartphones or home networks.

The main commercial advantage is automated data transmission, but manufacturers must reduce pairing complexity and connectivity failure because technical friction is a major cause of patient disengagement.

Cellular Remote Monitoring Devices

Cellular-connected devices are particularly valuable in clinical programs because they can transmit without requiring patient broadband, smartphone ownership, or manual pairing. This makes cellular monitoring attractive for older adults, underserved populations, and health-system deployments where reliability is more important than hardware cost.

AI-Enabled and Algorithmic Devices

AI-enabled systems use algorithms for trend identification, event detection, treatment recommendation, adherence assessment, or clinician prioritization. Their value will grow as home programs scale to thousands of patients and clinicians can no longer manually review every data stream.

Successful platforms will need transparent clinical validation, manageable alert burden, cybersecurity, and integration with care workflows.

Integrated Home-Care Ecosystems

Integrated ecosystems represent the long-term direction of the market. Rather than each device operating independently, monitoring, therapy, patient communication, electronic health records, pharmacy data, and caregiver alerts can function within one coordinated environment.

The FDA’s Home as a Health Care Hub initiative reflects this broader direction: the home is increasingly being considered as a clinical environment rather than simply the location where standalone equipment happens to be used.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Home-Based Care Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs substantially according to population growth, age distribution, chronic disease burden, Medicare enrollment, rurality, health-system concentration, hospital-at-home adoption, home health infrastructure, digital-health penetration, and the presence of HME supplier networks.

The South represents the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast has high-value health-system adoption and sophisticated post-acute infrastructure, while the Midwest provides a stable market supported by aging populations, chronic disease, established health systems, and extensive rural service requirements.

South

The South accounted for an estimated USD 11.84 billion in 2025, representing approximately 37% of the national market. Based on current demographic, clinical, and site-of-care trends, the region could approach USD 27.12 billion by 2035, implying growth above the national average.

The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia and the District of Columbia within the broader commercial market analysis.

Texas and Florida are the two most strategically important Southern markets. Texas combines a very large population with rapidly expanding metropolitan healthcare systems in Houston, Dallas–Fort Worth, Austin, and San Antonio. Its large geography also creates compelling economics for remote monitoring, home respiratory equipment, home infusion, and other technologies capable of reducing repeated travel to clinical facilities.

Florida is particularly attractive because of its large older adult population. Demand is strong across sleep therapy, oxygen equipment, diabetes monitoring, cardiac monitoring, mobility devices, hospital beds, rehabilitation systems, and post-discharge care technologies. Medicare exposure is high, which makes reimbursement strategy and relationships with DME suppliers particularly important.

North Carolina, Georgia, Tennessee, and Virginia represent major expansion markets. Each combines growing metropolitan populations with established academic and integrated health systems. Health-system consolidation in these states creates opportunities for enterprise device contracts covering post-acute monitoring, respiratory care, and hospital-to-home pathways.

Maryland and Delaware benefit from dense healthcare infrastructure and relatively strong access to specialty care. Their smaller geographic footprints can make home monitoring operationally efficient because provider networks can serve substantial patient populations across shorter distances.

Alabama, Mississippi, Kentucky, West Virginia, Arkansas, Louisiana, and Oklahoma offer a different commercial profile. Several of these states have high chronic disease and respiratory disease burdens, larger rural populations, and more limited specialty access. West Virginia, for example, has historically recorded one of the highest COPD prevalence levels in the country. These conditions support demand for oxygen therapy, respiratory monitoring, connected chronic-care devices, mobility systems, and remote clinical oversight.

Rurality is therefore both an opportunity and constraint in the South. Home-based devices can reduce transportation barriers and increase clinical reach, but broadband limitations, workforce shortages, patient affordability, and limited technical support can make complex connected solutions difficult to scale. Cellular connectivity, simplified workflows, and strong local DME partnerships can substantially improve adoption.

The South is expected to remain the largest regional market through 2035 because it combines high absolute population growth, rapid aging in several states, substantial diabetes and cardiovascular disease burden, expanding Medicare Advantage populations, and strong demand for alternatives to facility-based care.

West

The West accounted for an estimated USD 7.91 billion in 2025 and is projected to be the fastest-growing regional market, potentially reaching approximately USD 18.90 billion by 2035.

The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.

California is the largest Western state market and one of the most strategically important home-device markets nationally. Its scale, large integrated health systems, managed-care penetration, technology ecosystem, medtech presence, and advanced digital-health adoption make it a strong launch environment for connected monitoring systems and software-enabled home therapies.

California’s commercial attractiveness is particularly strong for continuous glucose monitoring, connected cardiovascular monitoring, home respiratory systems, post-acute virtual care, and integrated chronic-disease programs. At the same time, reimbursement complexity, diverse patient populations, high operating costs, and significant variation between metropolitan and rural communities require flexible go-to-market strategies.

Arizona and Nevada are high-growth markets because of rapid population expansion and significant older-adult migration. These demographic characteristics support respiratory therapy, mobility equipment, diabetes technology, blood-pressure monitoring, home rehabilitation, and post-discharge devices.

Washington and Oregon have sophisticated health-system environments and comparatively high acceptance of digital care. Integrated provider organizations can deploy connected medical devices across large patient populations under enterprise clinical protocols rather than individual physician purchasing.

Colorado and Utah combine population growth with advanced healthcare organizations and technology adoption. They are attractive markets for remote monitoring, home rehabilitation, cardiometabolic technologies, sleep therapy, and hospital-at-home infrastructure.

Idaho, Montana, Wyoming, Alaska, and New Mexico present smaller absolute revenue opportunities but strong use cases for remote care because patients may live far from tertiary health facilities. Devices capable of functioning with minimal technical infrastructure are especially important. Cellular connectivity, durable battery performance, remote troubleshooting, and simple user interfaces become major product differentiators.

Hawaii has unique logistical considerations because equipment distribution and replacement supplies must move across islands. Reliable inventory planning and local service partners are therefore especially important for respiratory equipment, mobility technology, and other devices requiring frequent consumable replacement.

The West is expected to gain national share because the region combines technology adoption, digital-health investment, managed-care sophistication, population migration, and relatively strong provider willingness to redesign clinical workflows around home monitoring.

Northeast

The Northeast represented an estimated USD 6.20 billion in 2025 and could reach approximately USD 13.14 billion by 2035.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania.

New York is the largest Northeast market, supported by its large population, major integrated delivery networks, extensive home-care infrastructure, and high concentration of specialty medical centers. The state contains highly sophisticated urban health systems as well as substantial rural areas, creating demand for both advanced connected-care technologies and conventional HME.

Massachusetts is disproportionately influential relative to its population because of its academic medical centers, digital-health ecosystem, clinical research infrastructure, and early technology adoption. New home-care devices frequently gain important clinical validation and physician advocacy through institutions in the state.

Pennsylvania is a significant market because of its aging population, large health-system networks, substantial Medicare enrollment, and mix of urban and rural communities. Home respiratory equipment, mobility technology, diabetes devices, cardiac monitoring, and post-acute equipment all have durable demand.

New Jersey benefits from population density, high healthcare utilization, major pharmaceutical and medical-technology activity, and proximity to New York and Philadelphia health systems. Dense geography improves the operating economics of home equipment delivery and technical service.

Connecticut and Rhode Island offer mature healthcare environments with relatively high specialist access. Adoption tends to favor clinically validated technologies with clear health-system economics.

Maine, Vermont, and New Hampshire have smaller populations but important older and rural communities. Remote monitoring and home care can be valuable in these states because travel distances to specialty providers can be significant.

The Northeast is likely to grow somewhat more slowly than the West and South because population growth is lower and healthcare infrastructure is already mature. However, the region should remain one of the highest-value markets for sophisticated monitoring, specialty therapy, and health-system-integrated home care.

Procurement standards are generally rigorous. Manufacturers frequently need strong clinical evidence, health-economic justification, cybersecurity documentation, interoperability, and dependable enterprise support to win major Northeast health-system contracts.

Midwest

The Midwest represented an estimated USD 5.70 billion in 2025 and could reach approximately USD 11.42 billion by 2035.

The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, and Missouri represent the primary revenue centers. These states contain large health systems, substantial chronic-disease populations, broad Medicare exposure, and extensive suburban and rural service territories.

Illinois benefits from Chicago’s large academic and integrated healthcare ecosystem. Connected post-acute monitoring, diabetes technology, sleep therapy, home respiratory care, and mobility equipment represent significant commercial categories.

Ohio is a major home-device market because of its large population and strong hospital systems. The state offers substantial demand across chronic respiratory disease, diabetes, cardiovascular monitoring, mobility, renal care, and post-discharge treatment.

Michigan similarly provides a large chronic-care and aging population base. Manufacturers with strong payer and health-system relationships can build significant recurring device and consumable revenue.

Minnesota is strategically important because of its medtech ecosystem, sophisticated providers, and culture of medical-device adoption. It also contains substantial rural geography, creating a useful test environment for connected home-care models.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but highly relevant to the underlying value proposition of home care. Rural populations can face long distances to specialists and tertiary hospitals, increasing the potential value of remote physiologic monitoring, home respiratory treatment, diabetes management, and telehealth-compatible equipment.

The Midwest’s market growth is expected to be below the national average, largely because population growth is slower than in the South and West. However, the region remains commercially dependable. Manufacturers that provide durable equipment, reliable supply chains, effective training, competitive contracting, and responsive service can maintain strong positions.

 

Key Market Players

The U.S. Home-Based Care Devices Competitive Landscape is fragmented across disease-specific device categories but increasingly consolidated around major connected-care platforms and national distribution channels.

Some of the most relevant companies participating across the U.S. home-based care device ecosystem include Abbott Laboratories, Dexcom, Medtronic, ResMed, Koninklijke Philips, Baxter International, Fresenius Medical Care, B. Braun, Becton Dickinson, Insulet Corporation, Omron Healthcare, Masimo, GE HealthCare, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Medline Industries, McKesson Corporation, Cardinal Health, Owens & Minor, AdaptHealth, React Health, Sunrise Medical, Permobil, Arjo, and Convatec.

Abbott and Dexcom hold strategically important positions in continuous glucose monitoring. Their competitive performance reflects sensor accuracy, wear duration, interoperability, reimbursement access, distribution, and increasingly consumer-oriented glucose monitoring.

Medtronic participates across diabetes technology and other connected medical-device categories, while Insulet is particularly important in tubeless insulin delivery and automated diabetes management.

ResMed is one of the strongest home respiratory and sleep-care competitors, with a model that combines devices, recurring accessories, cloud connectivity, adherence management, and home medical equipment relationships. Philips remains an important respiratory and monitoring participant despite the significant operational consequences created by historical respiratory-device recalls.

Fisher & Paykel Healthcare competes in respiratory therapy and associated technologies, while React Health and Drive DeVilbiss participate in home respiratory equipment and broader HME categories.

Baxter and Fresenius Medical Care are strategically important to the migration of renal treatment and other complex therapies toward home settings. B. Braun participates in infusion and specialty treatment technologies, while BD has strong capabilities in medication delivery, diabetes-adjacent care, infusion, and connected clinical technologies.

Omron is a major home blood-pressure monitoring brand, while Masimo and GE HealthCare have important capabilities in monitoring technologies that can increasingly extend beyond institutional care.

Medline, McKesson, Cardinal Health, Owens & Minor, AdaptHealth, and other distribution or HME organizations influence market access because home devices require logistics, reimbursement processing, patient onboarding, maintenance, and consumable fulfillment in addition to manufacturing.

Permobil, Sunrise Medical, Drive DeVilbiss, and Arjo are important in mobility, rehabilitation, patient handling, and home-support systems.

Competitive positioning through 2035 will increasingly depend on five capabilities: clinically reliable hardware, recurring consumable economics, connectivity, reimbursement integration, and ownership of the longitudinal patient relationship.

Companies selling isolated devices may face increasing pressure from platforms capable of integrating monitoring, therapy, adherence, clinician dashboards, supply replenishment, and outcomes reporting.

 

Recent Developments

Recent developments indicate that home-based care is moving from peripheral healthcare delivery toward formal U.S. healthcare infrastructure.

In April 2024, the FDA launched its Home as a Health Care Hub initiative. The program reflects recognition that medical devices intended for home care should not simply be hospital technologies transferred into residential environments. Device design must account for space limitations, patient ability, caregiver support, connectivity, housing conditions, usability, and interoperability.

The FDA subsequently expanded the initiative through its Idea Lab and Lilypad virtual environment. The initiative uses diabetes as an important use case because diabetes management can involve CGMs, glucose meters, insulin-delivery technologies, mobility devices, and other systems over the patient’s lifetime.

Another major development occurred in March 2024 when the FDA cleared the first over-the-counter continuous glucose monitor in the United States. This changed the commercial pathway for CGM by expanding potential access beyond traditional prescription-based intensive diabetes treatment.

In June 2026, the FDA further expanded OTC CGM access through clearance of the first OTC continuous glucose monitor indicated for qualifying pediatric users aged two years and older who do not use insulin. This development demonstrates how home-based medical technology is moving into broader patient populations.

Hospital-at-home policy has also become more strategically significant. CMS originally launched the Acute Hospital Care at Home initiative in 2020. Subsequent congressional action extended the associated authorities multiple times, and legislation enacted in 2026 extended the framework through September 30, 2030. This longer runway provides hospitals and device companies with greater confidence to invest in technologies supporting inpatient-level home care.

CMS reported in 2026 that nearly five years of Acute Hospital Care at Home data had become available for research, providing a substantially stronger evidence base for evaluating quality, utilization, patient selection, and economics.

Remote monitoring reimbursement also continues to evolve. Medicare already maintains payment pathways for remote physiologic monitoring and remote therapeutic monitoring, and CMS made additional refinements to remote-care policies in the 2026 Physician Fee Schedule. These policies reinforce the strategic importance of medical-grade connected devices capable of automatically transmitting clinically valid patient information.

The 2026 Medicare payment environment also continues to recognize home and remote management within broader care pathways. For manufacturers, this creates increasing pressure to demonstrate that devices improve outcomes in reimbursable care models rather than merely generate additional patient data.

The competitive market is simultaneously moving toward consolidation of device, software, and service capabilities. Respiratory manufacturers are building connected adherence ecosystems, diabetes companies are combining sensors with automated delivery, dialysis companies are investing in home treatment, and health systems are building longitudinal monitoring programs.

The next stage of competitive development is likely to center on interoperability and clinical automation. A home containing several connected medical devices generates limited value if every device requires a different application, login, dashboard, and workflow. Buyers will increasingly favor platforms that reduce complexity and present actionable information within existing clinical systems.

 

Conclusion

The U.S. Home-Based Care Devices Market Size & Share is positioned to expand from approximately USD 31.65 billion in 2025 to USD 70.58 billion by 2035, representing a CAGR of 8.35% during 2026–2035.

The market’s growth is supported by long-duration structural forces rather than a temporary post-pandemic shift. The United States has a rapidly aging population, high chronic-disease prevalence, extraordinary healthcare expenditure, increasing pressure on hospital capacity, substantial home health infrastructure, and a reimbursement system gradually incorporating remote and home-based clinical management.

Remote diagnostic and monitoring technologies will remain one of the strongest growth categories because they provide the data layer required for decentralized care. Continuous glucose monitoring, blood-pressure monitoring, cardiac surveillance, connected scales, pulse oximetry, and multi-parameter systems will increasingly be integrated into chronic-care programs rather than purchased as isolated devices.

Respiratory and sleep therapy will provide a large recurring installed base supported by COPD, sleep apnea, chronic respiratory disease, home oxygen requirements, and aging demographics. Connected therapy management will become increasingly important as providers seek to improve adherence without repeated in-person visits.

Diabetes technology will remain one of the most innovation-intensive areas. CGM, automated insulin delivery, tubeless pumps, connected medication administration, and consumer-accessible monitoring are transforming the home into the primary technology environment for diabetes management.

Home renal therapy, infusion, complex wound care, and higher-acuity monitoring offer some of the most strategically important opportunities because they directly shift expensive treatments away from hospitals and specialty facilities.

Mobility and patient-support equipment will remain essential even as digital technology attracts greater attention. Aging in place is impossible for many patients without wheelchairs, walkers, hospital beds, pressure-management products, patient lifts, transfer systems, and rehabilitation equipment. These categories therefore provide a durable demographic revenue base.

Regional opportunity will remain led by the South because of its population scale, rapid aging, chronic-disease burden, Medicare exposure, and large rural patient populations. Texas and Florida will be especially important national markets.

The West is expected to record the fastest growth because of digital-health adoption, managed-care penetration, technology-oriented provider organizations, and strong population migration. California, Arizona, Washington, Colorado, Nevada, and Utah should remain important early markets for connected home care.

The Northeast will retain its influence in clinical evidence generation, health-system purchasing, and sophisticated specialty care. New York, Massachusetts, Pennsylvania, and New Jersey will remain priority markets for premium technologies.

The Midwest will provide stable demand through aging populations, chronic disease, extensive integrated delivery networks, and large rural catchment areas. Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, and Missouri will remain the region’s primary revenue markets.

For manufacturers, investors, healthcare systems, distributors, and strategic buyers evaluating this industry, the fundamental question is no longer whether more healthcare will move into the home. The central strategic questions are which clinical pathways can move safely, which devices create measurable healthcare-system savings, who owns the resulting patient data, and which companies can make home technology simple enough for patients while maintaining the reliability expected by clinicians and payers.

The strongest competitors through 2035 will not necessarily be those with the largest individual device portfolio. They will be companies capable of connecting medical technology with reimbursement, logistics, patient adherence, caregiver usability, remote clinical workflow, supply replenishment, real-world evidence, and measurable healthcare economics.

Home-based care is consequently evolving from an equipment category into an increasingly important extension of the U.S. clinical infrastructure. Medical devices will be the physical and digital foundation enabling that transformation.

 

TABLE OF CONTENT

1. U.S. Home-Based Care Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Home-Based Care Device Manufacturers
1.6.2. Component, Sensor and Contract Manufacturing Suppliers
1.6.3. Hospitals, Health Systems and Hospital-at-Home Programs
1.6.4. Home Health Agencies and Specialty Home-Care Providers
1.6.5. Durable Medical Equipment and Home Medical Equipment Suppliers
1.6.6. Distributors, Pharmacies and Group Purchasing Organizations
1.6.7. Medicare, Medicaid, Commercial Payers, FDA and Clinical Decision-Makers

What this section provides: This section defines the U.S. home-based care devices market boundary, study scope, methodology, assumptions, device inclusion criteria, and stakeholder ecosystem so clients understand how the market is measured, segmented, validated, and forecast.

2. U.S. Home-Based Care Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Shift of Care from Institutional Settings to the Home
2.9. Connected Home-Care Device Adoption Snapshot

What this section provides: This section gives decision-makers a concise view of market size, historical development, forecast growth, leading device categories, high-growth care pathways, technology adoption, competitive intensity, and priority commercial opportunities.

3. U.S. Home-Based Care Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rapid Growth of the U.S. Aging Population
3.1.2. Rising Prevalence of Diabetes, Cardiovascular, Respiratory and Other Chronic Diseases
3.1.3. Increasing Preference for Aging in Place
3.1.4. Expansion of Remote Patient Monitoring and Connected Chronic-Care Programs
3.1.5. Growth of Hospital-at-Home and Higher-Acuity Home Care
3.1.6. Increasing Pressure to Reduce Hospital Admissions and Readmissions
3.1.7. Medicare and Commercial Payer Support for Home-Based Care Pathways

3.2. Restraints and Their Impact Analysis
3.2.1. Reimbursement Complexity Across Home Medical Equipment Categories
3.2.2. Patient Affordability and Out-of-Pocket Cost Burden
3.2.3. Device Connectivity, Interoperability and Digital Literacy Barriers
3.2.4. Product Recalls, Cybersecurity and Home-Use Safety Risks
3.2.5. Home-Care Workforce and Caregiver Availability Constraints
3.2.6. Variable Broadband and Cellular Connectivity in Rural Areas

3.3. Opportunities and Their Impact Analysis
3.3.1. Continuous Glucose Monitoring and Automated Diabetes Management
3.3.2. Connected Respiratory and Sleep Therapy Platforms
3.3.3. Multi-Parameter Remote Patient Monitoring
3.3.4. Home Dialysis and Specialty Home Therapy Expansion
3.3.5. Home Infusion and Advanced Wound-Care Device Adoption
3.3.6. Hospital-at-Home Device Infrastructure
3.3.7. AI-Assisted Home Monitoring and Predictive Deterioration Detection
3.3.8. Smart Mobility, Fall Prevention and Aging-in-Place Technologies

3.4. Challenges and Their Impact Analysis
3.4.1. Patient Adherence and Device Abandonment Risk
3.4.2. Alert Fatigue and Clinical Workflow Burden
3.4.3. Device Training and Technical Support Requirements
3.4.4. Fragmented Home-Care Technology Ecosystems
3.4.5. Data Privacy and Cybersecurity Compliance

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Home-Care Clinical Workflow Economics Analysis
3.7. Health-System and Home-Care Procurement Behavior Analysis
3.8. Total Cost of Care and Readmission Reduction Analysis
3.9. Aging-in-Place Economics and Caregiver Burden Analysis

What this section provides: This section explains the demographic, clinical, reimbursement, technological, economic, and operational forces shaping U.S. home-based care device demand and helps clients evaluate market upside, adoption barriers, reimbursement risks, and execution priorities.

4. U.S. Home-Based Care Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Home Care
4.6. Home-Use Medical Device Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Durable Medical Equipment Coverage
4.8.2. Remote Physiologic Monitoring Reimbursement
4.8.3. Remote Therapeutic Monitoring Reimbursement
4.8.4. Home Health and Post-Acute Reimbursement Considerations
4.8.5. Acute Hospital Care at Home Reimbursement Environment
4.9. Medicare Advantage and Commercial Payer Dynamics
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Home-Based Care Programs
4.12. FDA Home as a Health Care Hub Initiative
4.13. Impact of Escalating Geopolitical Tensions
4.14. Cybersecurity and Connected Medical Device Compliance
4.15. Health-System, DME and Home-Care Value Analysis Decision Framework

What this section provides: This section gives clients a comprehensive view of the external market environment, including regulation, Medicare coverage, reimbursement, device pricing, connected-care adoption, supply-chain exposure, cybersecurity, payer dynamics, and purchasing behavior.

5. U.S. Home-Based Care Devices Market – By Device Category

5.1. Overview
5.1.1. Segment Share Analysis, By Device Category, 2025 & 2035 (%)

5.1.2. Remote Diagnostic and Monitoring Devices
5.1.2.1. Blood Pressure Monitoring Devices
5.1.2.2. Continuous Glucose Monitoring Systems
5.1.2.3. Blood Glucose Meters
5.1.2.4. Pulse Oximeters
5.1.2.5. Home ECG and Ambulatory Cardiac Monitoring Devices
5.1.2.6. Connected Weight Scales
5.1.2.7. Digital Thermometers
5.1.2.8. Connected Spirometers
5.1.2.9. Multi-Parameter Patient Monitoring Systems
5.1.2.10. Other Home Diagnostic and Monitoring Devices

5.1.3. Respiratory and Sleep Therapy Devices
5.1.3.1. CPAP Devices
5.1.3.2. BiPAP Devices
5.1.3.3. Oxygen Concentrators
5.1.3.4. Oxygen Delivery Systems
5.1.3.5. Nebulizers
5.1.3.6. Home Ventilators
5.1.3.7. Airway Clearance Devices
5.1.3.8. Suction Devices
5.1.3.9. Respiratory Accessories and Consumables

5.1.4. Diabetes and Medication-Delivery Devices
5.1.4.1. Continuous Glucose Monitoring Systems
5.1.4.2. Insulin Pumps
5.1.4.3. Automated Insulin Delivery Systems
5.1.4.4. Smart Insulin Pens
5.1.4.5. Blood Glucose Monitoring Devices
5.1.4.6. Ambulatory Infusion Pumps
5.1.4.7. Connected Medication-Management Devices

5.1.5. Mobility, Rehabilitation and Patient-Support Devices
5.1.5.1. Manual Wheelchairs
5.1.5.2. Powered Wheelchairs and Mobility Scooters
5.1.5.3. Walkers, Canes and Crutches
5.1.5.4. Home Hospital Beds
5.1.5.5. Patient Lifts and Transfer Devices
5.1.5.6. Pressure-Relief Mattresses and Support Surfaces
5.1.5.7. Home Rehabilitation Devices
5.1.5.8. Bathroom Safety and Fall-Prevention Equipment

5.1.6. Home Renal, Infusion, Wound and Specialty Care Devices
5.1.6.1. Home Hemodialysis Systems
5.1.6.2. Peritoneal Dialysis Equipment
5.1.6.3. Home Infusion Pumps
5.1.6.4. Enteral Feeding Devices
5.1.6.5. Negative Pressure Wound Therapy Systems
5.1.6.6. Compression Therapy Devices
5.1.6.7. Specialty Suction and Drainage Equipment
5.1.6.8. Other Specialty Home-Care Devices

What this section provides: This section identifies the home-based care device categories expected to generate the largest revenue contribution and strongest growth through 2035, including connected monitoring, respiratory therapy, diabetes technology, mobility equipment, home renal systems, infusion devices, and advanced wound-care technologies.

6. U.S. Home-Based Care Devices Market – By Clinical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)

6.1.2. Cardiometabolic and Diabetes Management
6.1.2.1. Diabetes Management
6.1.2.2. Hypertension Management
6.1.2.3. Heart Failure Monitoring
6.1.2.4. Cardiac Rhythm Monitoring
6.1.2.5. Obesity-Associated Chronic Care

6.1.3. Respiratory and Sleep Disorder Management
6.1.3.1. Obstructive Sleep Apnea
6.1.3.2. Chronic Obstructive Pulmonary Disease
6.1.3.3. Chronic Respiratory Failure
6.1.3.4. Asthma and Airway Disease
6.1.3.5. Neuromuscular Respiratory Support

6.1.4. Renal and Specialty Infusion Care
6.1.4.1. Chronic Kidney Disease and End-Stage Renal Disease
6.1.4.2. Home Antibiotic Therapy
6.1.4.3. Nutritional Support
6.1.4.4. Oncology-Related Home Infusion
6.1.4.5. Pain and Specialty Medication Management

6.1.5. Mobility, Neurological and Rehabilitation Care
6.1.5.1. Stroke Rehabilitation
6.1.5.2. Neurological Disorders
6.1.5.3. Musculoskeletal Disorders
6.1.5.4. Frailty and Age-Related Mobility Limitations
6.1.5.5. Post-Surgical Rehabilitation
6.1.5.6. Fall Prevention and Functional Independence

6.1.6. Post-Acute, Complex and Multi-Chronic Care
6.1.6.1. Post-Hospital Discharge Monitoring
6.1.6.2. Hospital-at-Home Care
6.1.6.3. Complex Wound Management
6.1.6.4. Multi-Chronic Disease Management
6.1.6.5. Palliative and Supportive Home Care

What this section provides: This section helps clients understand home-based device demand by clinical use case and prioritize applications with strong disease burden, reimbursement relevance, recurring device utilization, hospital avoidance potential, and long-term technology adoption.

7. U.S. Home-Based Care Devices Market – By Care Delivery Model

7.1. Overview
7.1.1. Segment Share Analysis, By Care Delivery Model, 2025 & 2035 (%)

7.1.2. Patient and Family Caregiver-Managed Home Care
7.1.3. Home Health Agency-Supported Care
7.1.4. Hospital-at-Home and Health-System Programs
7.1.5. HME and DME Supplier-Supported Care
7.1.6. Specialty Home Therapy Providers
7.1.6.1. Home Respiratory Therapy Providers
7.1.6.2. Home Infusion Providers
7.1.6.3. Home Dialysis Providers
7.1.6.4. Home Wound-Care Providers
7.1.6.5. Remote Patient Monitoring Providers

What this section provides: This section explains how home medical devices are deployed across patient-managed, agency-supported, DME-supported, hospital-at-home, and specialty home therapy models and identifies which care pathways are expected to generate the strongest recurring equipment and monitoring demand.

8. U.S. Home-Based Care Devices Market – By Technology & Connectivity

8.1. Overview
8.1.1. Segment Share Analysis, By Technology & Connectivity, 2025 & 2035 (%)

8.1.2. Conventional Non-Connected Devices
8.1.3. Bluetooth and Wi-Fi Connected Devices
8.1.4. Cellular-Connected Remote Monitoring Devices
8.1.5. AI-Enabled and Algorithm-Assisted Devices
8.1.6. Integrated Home-Care Device Ecosystems

8.2. Interoperability with Electronic Health Records
8.3. Cloud-Based Device Management
8.4. Smartphone and Patient Application Integration
8.5. Cybersecurity and Data Protection
8.6. Predictive Monitoring and Clinical Alert Management

What this section provides: This section evaluates the connectivity and intelligence layers shaping home-based medical care, including conventional devices, wireless monitoring, cellular connectivity, AI-enabled systems, interoperability, cybersecurity, and integrated home-care platforms.

9. U.S. Home-Based Care Devices Market – By Procurement & Distribution Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement & Distribution Channel, 2025 & 2035 (%)

9.1.2. Direct Health-System and Hospital-at-Home Procurement
9.1.3. Home Medical Equipment and Durable Medical Equipment Suppliers
9.1.4. Home Health and Specialty Home-Care Provider Procurement
9.1.5. Distributor, Pharmacy and Group Purchasing Organization Channels
9.1.6. Retail, Direct-to-Consumer and Digital Commerce Channels

9.2. Medicare-Covered DME Fulfillment Model
9.3. Rental vs. Purchase Economics
9.4. Recurring Consumables and Replacement Supply Models
9.5. National vs. Regional HME Distribution Networks
9.6. Manufacturer Direct Contracting and Enterprise Agreements

What this section provides: This section helps clients understand how home-based care devices reach U.S. patients, including health-system procurement, Medicare DME channels, HME suppliers, specialty providers, pharmacies, distributors, direct-to-consumer models, equipment rental, and recurring consumable fulfillment.

10. U.S. Home-Based Care Devices Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Aging Population and Chronic Disease Burden Analysis
10.1.4. Regional Home Health, HME and DME Infrastructure Analysis
10.1.5. Regional Hospital-at-Home and Remote Monitoring Adoption
10.1.6. Regional Medicare, Reimbursement and Procurement Dynamics
10.1.7. Rural vs. Urban Home-Care Device Opportunity Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Home-Based Care Device Key Manufacturers, HME Suppliers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Home-Based Care Device Key Manufacturers, HME Suppliers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Home-Based Care Device Key Manufacturers, HME Suppliers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Home-Based Care Device Key Manufacturers, HME Suppliers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Care Delivery Model, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology & Connectivity, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement & Distribution Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and state-level analysis, helping clients identify priority U.S. geographies, aging-population clusters, chronic-disease demand centers, hospital-at-home adoption hotspots, rural-care opportunities, HME distribution requirements, and state-level commercial opportunities.

11. U.S. Home-Based Care Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players

11.3. Company Profiles

11.3.1. Abbott Laboratories

11.3.2. Dexcom, Inc.

11.3.3. Medtronic plc

11.3.4. ResMed Inc.

11.3.5. Koninklijke Philips N.V.

11.3.6. Baxter International Inc.

11.3.7. Fresenius Medical Care AG

11.3.8. B. Braun Melsungen AG

11.3.9. Becton, Dickinson and Company

11.3.10. Insulet Corporation

11.3.11. Omron Healthcare, Inc.

11.3.12. Masimo Corporation

11.3.13. GE HealthCare Technologies Inc.

11.3.14. Fisher & Paykel Healthcare Corporation Limited

11.3.15. Drive DeVilbiss Healthcare

11.3.16. Medline Industries, LP

11.3.17. McKesson Corporation

11.3.18. Cardinal Health, Inc.

11.3.19. Owens & Minor, Inc.

11.3.20. AdaptHealth Corp.

11.3.21. React Health

11.3.22. Sunrise Medical

11.3.23. Permobil

11.3.24. Arjo AB

11.3.25. Convatec Group Plc

11.4. Competitive Benchmarking by Device Category
11.5. Connected-Care Platform Capabilities Comparison
11.6. U.S. Distribution and HME Network Positioning
11.7. Reimbursement and Patient Access Strategy Comparison
11.8. Mergers, Acquisitions and Strategic Partnership Analysis

Note: Each company profile will include company overview, relevant home-based care device portfolio, U.S. market strategy, financial positioning, connected-care capabilities, regulatory developments, distribution partnerships, reimbursement positioning, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, connected-care capabilities, U.S. channel strength, innovation direction, reimbursement strategies, and strategic intelligence on leading home-based care device companies.

12. U.S. Home-Based Care Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Continuous and Multi-Parameter Remote Patient Monitoring
12.2.2. Automated Insulin Delivery and Next-Generation CGM
12.2.3. Connected Respiratory and Sleep Therapy
12.2.4. Compact Home Dialysis Technologies
12.2.5. AI-Assisted Deterioration Detection
12.2.6. Smart Mobility and Fall-Prevention Technologies
12.2.7. Connected Infusion and Medication-Delivery Systems
12.2.8. Integrated Home as a Health Care Hub Platforms

12.3. Emerging Business Trends
12.3.1. Device-as-a-Service Models
12.3.2. Subscription and Recurring Consumable Models
12.3.3. Risk-Based Contracting and Outcomes-Based Pricing
12.3.4. Hospital-to-Home Technology Partnerships
12.3.5. Direct-to-Consumer Medical Device Expansion
12.3.6. Consumerization of Medical-Grade Monitoring

12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Market White-Space Analysis
12.7. Expected Site-of-Care Migration Through 2035

What this section provides: This section prepares clients for future technology shifts, reimbursement changes, site-of-care migration, market-structure evolution, investment opportunities, emerging business models, and potential home-based care adoption scenarios through 2035.

13. U.S. Home-Based Care Devices Market: Strategic Recommendations

13.1. Recommendations for Home-Based Care Device Manufacturers
13.2. Recommendations for Hospitals and Health Systems
13.3. Recommendations for Hospital-at-Home Programs
13.4. Recommendations for Home Health and Specialty Home-Care Providers
13.5. Recommendations for HME and DME Suppliers
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Channel Partners
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Reimbursement and Market-Access Strategy
13.12. Connected-Care Partnership Strategy
13.13. State-Level Market Prioritization Framework
13.14. Rural Market Expansion Strategy
13.15. Clinical Evidence and Real-World Outcomes Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, U.S. market entry, reimbursement strategy, channel expansion, health-system partnerships, state prioritization, investment decisions, portfolio optimization, and competitive differentiation.

14. U.S. Home-Based Care Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Definition Limitation
14.4. Forecasting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Disclaimer

What this section provides: This section clarifies the report’s market boundaries, data-use limitations, forecasting assumptions, regulatory considerations, reimbursement limitations, third-party data conditions, and legal terms.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Home-Based Care Devices Market: Market Definition and Scope
TABLE 3: U.S. Home-Based Care Devices Market: Research Methodology Framework
TABLE 4: U.S. Home-Based Care Devices Market: Key Assumptions
TABLE 5: U.S. Home-Based Care Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Home-Based Care Devices Market: Stakeholder Analysis
TABLE 7: U.S. Home-Based Care Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Home-Based Care Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Home-Based Care Devices Market: Market Attractiveness Index
TABLE 10: U.S. Home-Based Care Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Home-Based Care Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Home-Based Care Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Home-Based Care Devices Market: Drivers & Impact Analysis
TABLE 14: U.S. Home-Based Care Devices Market: Restraints & Impact Analysis
TABLE 15: U.S. Home-Based Care Devices Market: Opportunities & Impact Analysis
TABLE 16: U.S. Home-Based Care Devices Market: Challenges & Impact Analysis
TABLE 17: U.S. Home-Based Care Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Home-Based Care Devices Market: Home-Care Clinical Workflow Economics Matrix
TABLE 19: U.S. Home-Based Care Devices Market: Health-System and Home-Care Procurement Behavior Matrix
TABLE 20: U.S. Home-Based Care Devices Market: Total Cost of Care and Readmission Reduction Analysis
TABLE 21: U.S. Home-Based Care Devices Market: Aging-in-Place and Caregiver Economics Analysis
TABLE 22: U.S. Home-Based Care Devices Market: PESTEL Analysis
TABLE 23: U.S. Home-Based Care Devices Market: Porter’s Five Forces Analysis
TABLE 24: U.S. Home-Based Care Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 25: U.S. Home-Based Care Devices Market: Value Chain Analysis
TABLE 26: U.S. Home-Based Care Devices Market: Supply Chain Analysis
TABLE 27: U.S. Home-Based Care Devices Market: Connected Home-Care Technology Landscape
TABLE 28: U.S. Home-Based Care Devices Market: FDA Regulatory Framework Analysis
TABLE 29: U.S. Home-Based Care Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 30: U.S. Home-Based Care Devices Market: Medicare Advantage and Commercial Payer Dynamics
TABLE 31: U.S. Home-Based Care Devices Market: FDA Home as a Health Care Hub Initiative
TABLE 32: U.S. Home-Based Care Devices Market: Cybersecurity and Connected Device Compliance Framework
TABLE 33: U.S. Home-Based Care Devices Market: Device Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Device Category
TABLE 35: U.S. Home-Based Care Devices Market, by Device Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Home-Based Care Devices Market: Segment Share Analysis, by Device Category, 2025 & 2035 (%)
TABLE 37: Remote Diagnostic and Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: Respiratory and Sleep Therapy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: Diabetes and Medication-Delivery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: Mobility, Rehabilitation and Patient-Support Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: Home Renal, Infusion, Wound and Specialty Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Home-Based Care Devices Market: Clinical Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 44: U.S. Home-Based Care Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Home-Based Care Devices Market: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 46: Cardiometabolic and Diabetes Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Respiratory and Sleep Disorder Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Renal and Specialty Infusion Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Mobility, Neurological and Rehabilitation Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Post-Acute, Complex and Multi-Chronic Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Home-Based Care Devices Market: Care Delivery Model Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Care Delivery Model
TABLE 53: U.S. Home-Based Care Devices Market, by Care Delivery Model, 2021–2035 (US$ Billion)
TABLE 54: U.S. Home-Based Care Devices Market: Segment Share Analysis, by Care Delivery Model, 2025 & 2035 (%)
TABLE 55: Patient and Family Caregiver-Managed Home Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Home Health Agency-Supported Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Hospital-at-Home and Health-System Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: HME and DME Supplier-Supported Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Specialty Home Therapy Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Home-Based Care Devices Market: Technology & Connectivity Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology & Connectivity
TABLE 62: U.S. Home-Based Care Devices Market, by Technology & Connectivity, 2021–2035 (US$ Billion)
TABLE 63: U.S. Home-Based Care Devices Market: Segment Share Analysis, by Technology & Connectivity, 2025 & 2035 (%)
TABLE 64: Conventional Non-Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Bluetooth and Wi-Fi Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Cellular-Connected Remote Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: AI-Enabled and Algorithm-Assisted Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Integrated Home-Care Device Ecosystems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Home-Based Care Devices Market: Procurement & Distribution Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement & Distribution Channel
TABLE 71: U.S. Home-Based Care Devices Market, by Procurement & Distribution Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Home-Based Care Devices Market: Segment Share Analysis, by Procurement & Distribution Channel, 2025 & 2035 (%)
TABLE 73: Direct Health-System and Hospital-at-Home Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: HME and DME Supplier Channel Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Home Health and Specialty Home-Care Provider Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Distributor, Pharmacy and GPO Channel Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Retail, Direct-to-Consumer and Digital Commerce Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Home-Based Care Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Home-Based Care Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Home-Based Care Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Home-Based Care Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Home-Based Care Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 84: California Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Washington Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Arizona Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Colorado Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Oregon Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Utah Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Nevada Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: New Mexico Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Idaho Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Montana Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Wyoming Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Alaska Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Hawaii Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Northeast Region U.S. Home-Based Care Devices Market: Regional Overview and Trends
TABLE 98: Northeast Region U.S. Home-Based Care Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 99: New York Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Massachusetts Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: New Jersey Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Pennsylvania Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Connecticut Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Maine Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Vermont Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: New Hampshire Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Rhode Island Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Delaware Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: South Region U.S. Home-Based Care Devices Market: Regional Overview and Trends
TABLE 110: South Region U.S. Home-Based Care Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 111: Texas Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Florida Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Georgia Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: North Carolina Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Tennessee Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: South Carolina Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Alabama Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Mississippi Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Louisiana Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Arkansas Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Kentucky Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Oklahoma Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Virginia Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Maryland Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: West Virginia Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Midwest Region U.S. Home-Based Care Devices Market: Regional Overview and Trends
TABLE 127: Midwest Region U.S. Home-Based Care Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 128: Illinois Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Ohio Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Michigan Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Minnesota Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Indiana Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Wisconsin Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Missouri Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Iowa Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Kansas Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Nebraska Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: North Dakota Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: South Dakota Home-Based Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: U.S. Home-Based Care Devices Market: Competitive Landscape Snapshot, 2025
TABLE 141: U.S. Home-Based Care Devices Market: Key Company Market Share Analysis, 2025
TABLE 142: U.S. Home-Based Care Devices Market: Company Positioning Matrix
TABLE 143: U.S. Home-Based Care Devices Market: Device Portfolio Benchmarking of Key Players
TABLE 144: U.S. Home-Based Care Devices Market: Connected-Care Platform Capabilities Comparison
TABLE 145: Abbott Laboratories: Company Profile
TABLE 146: Dexcom, Inc.: Company Profile
TABLE 147: Medtronic plc: Company Profile
TABLE 148: ResMed Inc.: Company Profile
TABLE 149: Koninklijke Philips N.V.: Company Profile
TABLE 150: Baxter International Inc.: Company Profile
TABLE 151: Fresenius Medical Care AG: Company Profile
TABLE 152: B. Braun Melsungen AG: Company Profile
TABLE 153: Becton, Dickinson and Company: Company Profile
TABLE 154: Insulet Corporation: Company Profile
TABLE 155: Omron Healthcare, Inc.: Company Profile
TABLE 156: Masimo Corporation: Company Profile
TABLE 157: GE HealthCare Technologies Inc.: Company Profile
TABLE 158: Fisher & Paykel Healthcare Corporation Limited: Company Profile
TABLE 159: Drive DeVilbiss Healthcare: Company Profile
TABLE 160: Medline Industries, LP: Company Profile
TABLE 161: McKesson Corporation: Company Profile
TABLE 162: Cardinal Health, Inc.: Company Profile
TABLE 163: Owens & Minor, Inc.: Company Profile
TABLE 164: AdaptHealth Corp.: Company Profile
TABLE 165: React Health: Company Profile
TABLE 166: Sunrise Medical: Company Profile
TABLE 167: Permobil: Company Profile
TABLE 168: Arjo AB: Company Profile
TABLE 169: Convatec Group Plc: Company Profile
TABLE 170: U.S. Home-Based Care Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 171: U.S. Home-Based Care Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 172: U.S. Home-Based Care Devices Market: Disruptive Technologies Impact Matrix
TABLE 173: U.S. Home-Based Care Devices Market: Emerging Business Trends
TABLE 174: U.S. Home-Based Care Devices Market: Business Opportunities for Startups and Existing Players
TABLE 175: U.S. Home-Based Care Devices Market: Investment Prioritization Matrix
TABLE 176: U.S. Home-Based Care Devices Market: Market White-Space Analysis
TABLE 177: U.S. Home-Based Care Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 178: U.S. Home-Based Care Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 179: U.S. Home-Based Care Devices Market: Strategic Recommendations for Home-Care and HME Providers
TABLE 180: U.S. Home-Based Care Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 181: U.S. Home-Based Care Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 182: U.S. Home-Based Care Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 183: U.S. Home-Based Care Devices Market: Go-to-Market Strategy Considerations
TABLE 184: U.S. Home-Based Care Devices Market: Reimbursement and Market-Access Strategy Framework
TABLE 185: U.S. Home-Based Care Devices Market: State-Level Market Prioritization Framework
TABLE 186: U.S. Home-Based Care Devices Market: Scope Limitation
TABLE 187: U.S. Home-Based Care Devices Market: Data Use Limitation
TABLE 188: U.S. Home-Based Care Devices Market: Market Definition Limitation
TABLE 189: U.S. Home-Based Care Devices Market: Forecasting Limitation
TABLE 190: U.S. Home-Based Care Devices Market: Legal Disclaimer
TABLE 191: U.S. Home-Based Care Devices Market: Third-Party Data Disclaimer
TABLE 192: U.S. Home-Based Care Devices Market: Regulatory and Reimbursement Disclaimer

List of Figures

FIGURE 1: U.S. Home-Based Care Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Home-Based Care Devices Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Framework
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. Home-Based Care Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Home-Based Care Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Home-Based Care Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. Home-Based Care Devices Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Home-Care Clinical Workflow Economics Framework
FIGURE 12: Health-System and Home-Care Procurement Decision Framework
FIGURE 13: Aging-in-Place and Caregiver Economics Framework
FIGURE 14: PESTEL Analysis
FIGURE 15: Porter’s Five Forces Analysis
FIGURE 16: Value Chain Analysis
FIGURE 17: Supply Chain Analysis
FIGURE 18: Connected Home-Care Technology Landscape
FIGURE 19: FDA and CMS Regulatory-Reimbursement Framework
FIGURE 20: Home-Based Medical Device Cybersecurity Framework
FIGURE 21: Device Category Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Device Category Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Remote Diagnostic and Monitoring Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 24: Respiratory and Sleep Therapy Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 25: Diabetes and Medication-Delivery Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 26: Mobility, Rehabilitation and Patient-Support Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 27: Home Renal, Infusion, Wound and Specialty Care Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 28: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 29: Clinical Application Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Cardiometabolic and Diabetes Management Market Forecast, 2021–2035
FIGURE 31: Respiratory and Sleep Disorder Management Market Forecast, 2021–2035
FIGURE 32: Renal and Specialty Infusion Care Market Forecast, 2021–2035
FIGURE 33: Mobility, Neurological and Rehabilitation Care Market Forecast, 2021–2035
FIGURE 34: Post-Acute, Complex and Multi-Chronic Care Market Forecast, 2021–2035
FIGURE 35: Care Delivery Model Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Care Delivery Model Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Patient and Family Caregiver-Managed Home Care Growth Trend
FIGURE 38: Home Health Agency-Supported Care Growth Trend
FIGURE 39: Hospital-at-Home and Health-System Program Growth Trend
FIGURE 40: HME and DME Supplier-Supported Care Growth Trend
FIGURE 41: Specialty Home Therapy Provider Growth Trend
FIGURE 42: Technology & Connectivity Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Technology & Connectivity Market Size Forecast, 2021–2035
FIGURE 44: Connected Home Medical Device Adoption Roadmap
FIGURE 45: Cellular Remote Monitoring Adoption Framework
FIGURE 46: AI-Enabled Home-Care Device Opportunity Map
FIGURE 47: Integrated Home-Care Device Ecosystem Framework
FIGURE 48: Procurement & Distribution Channel Market Share Analysis, 2025 & 2035
FIGURE 49: Procurement & Distribution Channel Market Size Forecast, 2021–2035
FIGURE 50: U.S. Home Medical Equipment Distribution Ecosystem
FIGURE 51: Medicare DME Fulfillment and Reimbursement Pathway
FIGURE 52: Equipment Rental vs. Purchase Economics Framework
FIGURE 53: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: West Region U.S. Home-Based Care Devices Market Share and Leading Players, 2025
FIGURE 56: West Region Market Share Analysis by State, 2025
FIGURE 57: California Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 58: Washington Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 59: Arizona Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 60: Colorado Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 61: Oregon Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 62: Utah Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 63: Nevada Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 64: New Mexico Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 65: Idaho Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 66: Montana Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 67: Wyoming Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 68: Alaska Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 69: Hawaii Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 70: Northeast Region U.S. Home-Based Care Devices Market Share and Leading Players, 2025
FIGURE 71: Northeast Region Market Share Analysis by State, 2025
FIGURE 72: New York Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 73: Massachusetts Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 74: New Jersey Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 75: Pennsylvania Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 76: Connecticut Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 77: Maine Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 78: Vermont Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 79: New Hampshire Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 80: Rhode Island Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 81: Delaware Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 82: South Region U.S. Home-Based Care Devices Market Share and Leading Players, 2025
FIGURE 83: South Region Market Share Analysis by State, 2025
FIGURE 84: Texas Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 85: Florida Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 86: Georgia Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 87: North Carolina Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 88: Tennessee Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 89: South Carolina Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 90: Alabama Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 91: Mississippi Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 92: Louisiana Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 93: Arkansas Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 94: Kentucky Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 95: Oklahoma Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 96: Virginia Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 97: Maryland Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 98: West Virginia Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 99: Midwest Region U.S. Home-Based Care Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Illinois Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 102: Ohio Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 103: Michigan Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 104: Minnesota Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 105: Indiana Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 106: Wisconsin Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 107: Missouri Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 108: Iowa Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 109: Kansas Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 110: Nebraska Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 111: North Dakota Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 112: South Dakota Home-Based Care Devices Market Size and Trend Analysis, 2021–2035
FIGURE 113: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 114: Company Positioning Matrix
FIGURE 115: Key Player Device Portfolio Benchmarking
FIGURE 116: Connected-Care Platform Capabilities Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: U.S. Home-Based Care Device Innovation Roadmap
FIGURE 119: Remote Patient Monitoring Growth Roadmap
FIGURE 120: Connected Respiratory and Sleep Therapy Opportunity Map
FIGURE 121: Diabetes Technology and Automated Delivery Growth Roadmap
FIGURE 122: Home Dialysis and Specialty Therapy Opportunity Map
FIGURE 123: Future Market Scenario Analysis, 2026–2035
FIGURE 124: Disruptive Technologies Impact Matrix
FIGURE 125: Emerging Business Trends Matrix
FIGURE 126: Market White-Space Opportunity Map
FIGURE 127: Investment Prioritization Matrix
FIGURE 128: Strategic Growth Roadmap for U.S. Home-Based Care Device Companies
FIGURE 129: Go-to-Market Strategy Framework
FIGURE 130: Reimbursement and Market-Access Strategy Framework
FIGURE 131: State-Level Market Prioritization Framework
FIGURE 132: Product Positioning and Portfolio Expansion Framework
FIGURE 133: Report Scope and Disclaimer Framework